Claims for Patent: 3,655,663
✉ Email this page to a colleague
Summary for Patent: 3,655,663
| Title: | 4-(3-secondary amino-2-hydroxy-proxy) 1 2 5-thiadiazoles |
| Abstract: | 4-(3-(SUBSTITUTED AMINO)-2-HYDROXUPROPOXY)-1,2,5-THIADIAZOLE COMPOUNDS, OPTIONALLY SUBSTITUTED IN THE 3-POSITION OF THE THIADIAZOLE NUCLEUS WHICH EXHIBITS B-ADRENERGIC BLOCKING PROPERTIES AND THUS ARE USEFUL IN THE MANAGEMENT OF ANGINA PECTORIS ARE DESCRIBED. THE PRODUCTS ARE PREPARED BY ONE OF FOUR PRINCIPAL METHODS (1) REACTION OF A 4-HYDROXY-1,2,5-THIADIAZOLE WITH EPIHALOYDRINE TO PROVIDE 4-(3 HALO-2-HYDROXYPROPOXY)-1,2,5-THIADIAZOLE WHICH UPON TREATMENT WIHT ALKALI, FORMS THE EPOXIDE WHICH IS THEN REACTED WITH AN AMINE TO PROVIDE THE DESIRED PRODUCT; (2) REACTION OF A 3-CHLORO(OR BROMO)-4-(3-SUBSTITUTED AMINO-2-HYDROXYPROPOXY)-1,2,5-THIADIAZOLE WITH AN AMINE OR AN N-CONTAINING HETEROCYCLE THAT REPLACES THE 3-CHLOROGROUP; (3) REACTION OF 3-CARBOXY-4-ALLYLOXY-1,2,5-THIADIAZOLE WITH N-BROMOSUCCINIMIDE FOLLOWED BY ESTERIFICATION TO GIVE THE ALKYL ESTER OF 3-CARBOXY-4(3-BROMO-2-HYDROXYPROPOXYL)-1,2,5-THIADIAZOLE WHICH UPON TREATMENT WITH AN AMINE FORMS A 3-CARBONOYL-4-(3SUBSTITUTED AMINO-2-HYDROXYPROPOXY)-1,2,5-THIADIAZOLE AND (4) REDUCTIVE ALKYLATION OF AN R-O-CH2-CO-CH-N2, R-O-CH2-CO-CN3, R-O-CH2-CO-CH=N-OH, R-O-CH2-CO-CH2-NO2, R-O-CH2-CH(-OH)-CH2-NO2, R-O-CH2-CH(-OH)-CN, OR R-O-CH2-CO-CN WHEREIN R IS THE 1,2,5-THIADIAZOLE-4-YL GROUP. |
| Inventor(s): | Burton K Wasson |
| Assignee: | BURTON K WASSON , Merck Frosst Canada and Co |
| Application Number: | US818090A |
| Patent Claims: |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
